港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

天辰生物-B

144.100

+2.2001.55%

成交量：8.98萬

成交額：1,292.04萬

市值：106.91億

市盈率：-52.73

高：146.000

開：141.600

低：141.400

收：141.900

52周最高：158.000

52周最低：116.100

股本：7,419.32萬

香港流通股本：7,293.03萬

量比：0.15

換手率：0.12%

股息：- -

股息率：- -

每股收益(LYR):-2.733

淨資產收益率：--

總資產收益率：-54.56%

市淨率：65.69

市盈率(LYR):-52.73

市銷率: - -

資料載入中...

總覽公司新聞資訊公告

天辰生物-B(01779)：LP-003針對季節性過敏性鼻炎適應症的III期臨床試驗達到主要終點

天辰生物-B：LP-3治療季節性過敏性鼻炎III期臨床試驗達到主要終點

暴漲50%，89歲「藥神」啱啱敲鐘了

進入最後一個月倒計時，天辰生物-B(01779)能否在入通前撐起高位估值？

異動解讀｜天辰生物-B盤中上漲6.37%，上市次日延續IPO超購熱度

【特約大V】鄧聲興：加息風暴席捲，港股料尋底

新股消息 | 威兆半導體擬港股IPO 中國證監會要求補充説明威鑄燁芯和舟山集成股權激勵價格差異原因及合理性等

中國過敏及自免領域創新藥領軍企業天辰生物成功登陸香港交易所

港股收盤(06.05) | 恒指收跌1.15%失守兩萬五半導體股顯著回調三新股首日表現分化

【IPO追蹤】認購情緒高漲！天辰生物（01779.HK）首日跳空飆升

天辰生物(01779.HK)，正式掛牌上市，股價高開超50%

異動解讀 | 天辰生物-B首日掛牌盤中大漲54.80%，獲超4700倍超額認購引爆市場熱情

異動解讀｜天辰生物-B盤中上漲51.05%，首掛上市獲超4762倍超額認購

新股首日 | 天辰生物-B(01779)首掛上市早盤高開50.22% 核心產品LP-003已在中國啓動八項臨床試驗

《股市簡訊》中國天辰生物香港首秀盤初急漲64%，大金重工與龍豐集團雙雙「潛水」

港股開盤 | 恒指低開0.27%，科指低開0.31%！天辰生物-B首掛升逾50%

老虎资讯综合

新股定價 | 天辰生物-B每股定價96.06港元，公開發售超購4762.58倍，一手中籤率2%

老虎资讯综合

天辰生物-B(01779)：香港公開發售獲4762.58倍認購全球發售淨籌約12.55億港元

天辰生物-B獲4,763倍超購、募資逾13億元　6月5日登陸港交所

新股暗盤 | 天辰生物-B(01779)暗盤盤初漲逾135% 每手賺6487港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01779/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01779","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","market":"HK","secType":"STK","nameCN":"天辰生物-B","latestPrice":144.1,"timestamp":1781241755230,"preClose":141.9,"halted":0,"volume":89750,"delay":0,"changeRate":0.015503875968992168,"floatShares":72930300,"shares":74193200,"eps":-2.733,"marketStatus":"交易中","change":2.2,"latestTime":"06-12 13:22:55","open":141.6,"high":146,"low":141.4,"amount":12920380,"amplitude":0.032417,"askPrice":144.3,"askSize":150,"bidPrice":143.6,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.62,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1781251800000},"marketStatusCode":2,"adr":0,"listingDate":1780588800000,"exchange":"SEHK","adjPreClose":141.9,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.146927,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","floatShares":72930300,"roa":"-54.56%","roe":"--","lyrEps":-2.733,"volumeRatio":0.146927,"shares":74193200,"dividePrice":0,"high":146,"amplitude":0.032417,"preClose":141.9,"low":141.4,"week52Low":116.1,"pbRate":"65.69","week52High":158,"institutionHeld":0,"latestPrice":144.1,"committee":-0.2,"eps":-2.733,"divideRate":0,"volume":89750,"delay":0,"ttmEps":-2.62,"open":141.6,"prevYearClose":96.06,"prevWeekClose":131.8,"prevMonthClose":96.06,"prevQuarterClose":96.06,"fiveDayClose":131.8,"twentyDayClose":96.06,"sixtyDayClose":96.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01779\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01779\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01779\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01779\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01779","date":"2026-06-10","current":-54.160305,"percent":0.5,"low":-51.066007,"twenty":-50.731195,"median":-50.228977,"eighty":-47.272196,"high":-45.301009,"avg":-48.865331,"sd":2.543416,"marketCap":10201558125},"quantilePoints":[{"date":"2026-06-10","current":-50.228977,"twenty":-50.731195,"median":-50.228977,"eighty":-47.272196,"marketCap":10201558125}],"updateTime":1781201444863},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01779\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642237531","title":"天辰生物-B(01779)：LP-003針對季節性過敏性鼻炎適應症的III期臨床試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2642237531","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642237531?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 06:16","pubTimestamp":1781216203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天辰生物-B 发布公告，LP-003针对季节性过敏性鼻炎的III期临床试验已达到预先设定的主要终点，且该等结果在统计学及临床方面均具有高度重要性。LP-003针对季节性过敏性鼻炎适应症的III期临床试验是一项在中国开展的多中心、随机、双盲、安慰剂对照的III期临床研究，旨在比较LP-003与安慰剂治疗经标准治疗控制不佳的中重度季节性过敏性鼻炎的效果。主要排除标准为患有季节性过敏性鼻炎以外的合并症的患者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01779","BK4134","III"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1123467918","title":"天辰生物-B：LP-3治療季節性過敏性鼻炎III期臨床試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1123467918","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123467918?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 06:13","pubTimestamp":1781215995,"startTime":"0","endTime":"0","summary":"天辰生物-B宣布，其用于治疗季节性过敏性鼻炎的候选药物LP-3，在关键的III期临床试验中成功达到了预设的主要疗效终点。这一积极结果标志着该药物在临床开发道路上取得了重大进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642549597","title":"暴漲50%，89歲「藥神」啱啱敲鐘了","url":"https://stock-news.laohu8.com/highlight/detail?id=2642549597","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642549597?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 22:38","pubTimestamp":1781015885,"startTime":"0","endTime":"0","summary":"2020年，这位生物医药界公认的“药神”级人物，在超80岁高龄之际再度出山，且只花了六年时间便将一家初创公司送上了资本市场。LP-003的季节性过敏性鼻炎三期临床试验已于2024年完成首名患者入组，目标是在2026年第三季度提交上市申请。此次港股IPO，天辰生物以18A章未盈利生物科技公司身份登陆。于2024年及2025年，天辰生物的全面亏损总额分别为1.37亿元和1.76亿元。关于经营亏损原因，公司归因于“研发成本、行政开支及财务成本”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1780628916795914060","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","BK4581","XBI","IPOS","BK4585","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642462623","title":"進入最後一個月倒計時，天辰生物-B(01779)能否在入通前撐起高位估值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642462623?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 19:26","pubTimestamp":1781004367,"startTime":"0","endTime":"0","summary":"上市次日，天辰生物场内表现较为低迷，股价全天在水下波动，最终收跌6.83%。此次天辰生物的发行比例是19.13%，基石锁定49.96%，流通盘约为6.82亿港元，其释出的公开发售数量为28387手，并且入场费达到4851.44港元。目前天辰生物检讨周期内日平均市值为90.77亿港元，市值覆盖率为94.61%，而截至6月8日公司收盘价为124港元。但就在这种情况下，天辰生物的此次IPO发行市值却达到了71.27亿港元，较C轮估值大涨226.57%，而这在短期内或透支了公司估值成长预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118653094","title":"異動解讀｜天辰生物-B盤中上漲6.37%，上市次日延續IPO超購熱度","url":"https://stock-news.laohu8.com/highlight/detail?id=1118653094","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118653094?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 09:33","pubTimestamp":1780968791,"startTime":"0","endTime":"0","summary":"6月9日，天辰生物-B盘中上涨6.37%，报139.3港元，成交额775.71万港元，较招股价96.06港元累计溢价约45%。消息面上，天辰生物-B于6月5日正式登陆港交所，其香港公开发售部分获得高达4762.58倍超额认购，一手中签率仅约2%，市场认购热情极高。天辰生物是一家临床阶段生物制药公司，专注于过敏性及自身免疫性疾病生物药物的自主发现与开发，核心产品LP-003为抗IgE抗体，已在中国启动八项临床试验。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641772151","title":"【特約大V】鄧聲興：加息風暴席捲，港股料尋底","url":"https://stock-news.laohu8.com/highlight/detail?id=2641772151","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641772151?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 10:05","pubTimestamp":1780884348,"startTime":"0","endTime":"0","summary":"国指跌65点或0.77%，报8436点。摩根大通把特斯拉目标价大幅上调至475美元，特斯拉股价仍跌6.6%。瑜伽服装品牌Lululemon下调收入预测，股价泻8.6%。加息风暴席卷，港股料寻底。中国移动中国移动集团正从传统通信运营商向AI基础设施服务商进行结构性跃迁。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983222","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","TLT","LU1226287875.USD","TLTW","VXUS","HK0000288743.USD","HK0000352382.USD","80883","LU1226287792.SGD","BK1506","US10Y.BOND","LU1951186391.HKD","BK4588","HK0000352291.HKD","US30Y.BOND","US2Y.BOND","01081","LU1960683339.HKD","01779","LU0039217434.USD","BK4585","HK0000288784.HKD","BK1152","LU1497733631.SGD","US12M.BOND","LU1152091168.USD","BK1589","US6M.BOND","BK1536","LU1634259391.SGD","LU1993786604.SGD","BK1610","US5Y.BOND","LU1064131003.USD","LU1481107354.HKD","LU0871576103.HKD","HK0000286598.CNH","LU1522347837.USD","TMF","LU0880133367.SGD","BK1205","LU1226287529.USD","US3Y.BOND","US7Y.BOND","HK0000252160.HKD","00941","LU1497734951.SGD","SG9999002463.SGD","LU1152091754.HKD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641146875","title":"新股消息 | 威兆半導體擬港股IPO 中國證監會要求補充説明威鑄燁芯和舟山集成股權激勵價格差異原因及合理性等","url":"https://stock-news.laohu8.com/highlight/detail?id=2641146875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641146875?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 22:01","pubTimestamp":1780668088,"startTime":"0","endTime":"0","summary":"中国证监会国际司共对10家企业出具补充材料要求。其中，要求威兆半导体补充说明威铸烨芯和舟山集成两次股权激励授予价格差异较大的原因及合理性等。中国证监会请威兆半导体补充说明以下事项，请律师进行核查并出具明确的法律意见：一、请说明：最近12个月内新增股东入股价格的合理性，不同股东入股价格存在差异的原因;就最近12个月内新增股东入股价格是否公允合理、是否存在利益输送出具明确结论性意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641149271","title":"中國過敏及自免領域創新藥領軍企業天辰生物成功登陸香港交易所","url":"https://stock-news.laohu8.com/highlight/detail?id=2641149271","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641149271?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 16:39","pubTimestamp":1780648740,"startTime":"0","endTime":"0","summary":"上海2026年6月5日 /美通社/ -- 北京时间2026年6月5日，启明创投投资企业、中国过敏及自免领域的创新药领军企业天辰生物成功登陆港交所，至此启明创投迎来开年第7个IPO。2024年，启明创投领投了天辰生物B2轮融资，后又于2025年联合领投天辰生物C轮融资。IPO前，启明创投持有天辰生物4.27%的股份，为主要机构投资方之一。天辰生物成立于2020年，主要专注于针对过敏性及自身免疫性疾病的生物药物的自主发现与开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4976870_ZH76870_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0359201885.HKD","LU0762540952.USD","IE00BKZH1Z71.USD","LU0819121731.USD","LU0708995583.HKD","LU0314109678.HKD","LU0072462343.USD","LU0061477393.USD","IE0003795394.USD","LU0117844026.USD","01779","LU0096374516.USD","BK1589","LU0043850808.USD","LU0648948544.HKD","LU0821914370.USD","LU0651946864.USD","00388","BK1574","LU0634319403.HKD","LU1282649141.HKD","LU0417516902.SGD","LU0819123356.HKD","SG9999004220.SGD","LU1242518931.SGD","LU0650527681.SGD","80388","LU0918141705.HKD","HKXCY","LU0164880469.USD","LU1044874839.SGD","LU0011963245.USD","LU0873338254.USD","06978","LU1226287529.USD","LU0359201612.USD","LU0791590937.USD","LU0607220059.USD","HK0000151867.HKD","LU0516422952.EUR","SG9999001051.SGD","LU1044876610.USD","LU1642822792.SGD","LU0886674414.USD","LU0979878070.USD","LU0577902371.SGD","HEXmain","LU0211977185.USD","LU0067412154.USD","LU0577902611.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641168031","title":"港股收盤(06.05) | 恒指收跌1.15%失守兩萬五 半導體股顯著回調 三新股首日表現分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2641168031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641168031?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 16:32","pubTimestamp":1780648331,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数跌1.15%或291.45点，报24961.95点，全日成交额3428.05亿港元；恒生国企指数跌0.77%，报8436.63点；恒生科技指数跌1.75%，报4888.39点。截至收盘，涨6%，报143.2港元，成交额3亿港元，贡献恒指1.67点。截至收盘，澜起科技跌9.21%，报368.8港元；兆易创新跌8.02%，报723.0港元；中芯国际跌7.18%，报75.65港元；华虹半导体跌7.16%，报145.3港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159582","00316","FTXL","TEKX","VGT","SOXX","513600","01779","SOXY","02290","83115","02800","07200","PSI","SOXQ","LU1152091754.HKD","03419","VXUS","CHPY","BK1526","03143","07300","82800","LU0149534421.HKD","LU0067412154.USD","STAN.UK","MHImain","LU0211977185.USD","SOXL","SMH","XSD","SOXS","HHImain","BK1163","SMHX","02888","MCHmain","02833","03037","SSG","03115","HSI","00981","06809","USD","09115","SG9999000327.SGD","CHPS","HSImain","07500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148865","title":"【IPO追蹤】認購情緒高漲！天辰生物（01779.HK）首日跳空飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148865","media":"IPO解码","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641148865?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 16:17","pubTimestamp":1780647420,"startTime":"0","endTime":"0","summary":"而在6月5日，新股市场又迎来三股同日上市，其中天辰生物-B走势最强，股价迎来跳空上涨，截至发稿时间涨近48%，股价为142港元。此外，国际配售阶段，天辰生物获10.94倍认购，国际发售股份最终数目为1277.38万股，相当于发售股份总数的90%。从数据来看，天辰生物的公开发售获得了投资者的热烈追捧，认购情绪高涨。天辰生物的最终发售价为96.06港元，截至发稿时间，其股价现为142港元，每手50股，不计手续费，一手赚2297港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkzmt/2026-06-05/doc-iniaiyys8453645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148288","title":"天辰生物(01779.HK)，正式掛牌上市，股價高開超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148288","media":"财通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641148288?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 11:10","pubTimestamp":1780629000,"startTime":"0","endTime":"0","summary":"6月5日上午，天辰生物医药(苏州)股份有限公司正式于港交所主板挂牌上市。上市首日，天辰生物高开50.22%，盘中最高触及158港元，涨幅高达64.48%。最终发行价为每股96.06港元，天辰生物此次IPO募资总额为13.63亿港元。天辰生物成立于2020年，是一家临床阶段生物制药公司，主要专注于针对过敏性及自身免疫性疾病的生物药物的自主发现与开发。2024年至2025年，天辰生物并无产生任何收入或任何营业成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkzmt/2026-06-05/doc-iniaiqkw8571438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01779","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193234584","title":"異動解讀 | 天辰生物-B首日掛牌盤中大漲54.80%，獲超4700倍超額認購引爆市場熱情","url":"https://stock-news.laohu8.com/highlight/detail?id=1193234584","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193234584?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 09:35","pubTimestamp":1780623326,"startTime":"0","endTime":"0","summary":"天辰生物-B今日盘中大幅上涨54.80%，成为市场关注的焦点。消息面上，天辰生物-B今日正式在港交所主板挂牌上市，作为首日挂牌的新股，其香港公开发售部分获得了高达4762.58倍的超额认购，显示出市场极高的认购热情和资金追捧。此前暗盘交易该股已录得显著涨幅，为上市首日的强势表现奠定了基调。天辰生物-B是一家临床阶段的生物制药公司，专注于针对过敏性及自身免疫性疾病的生物药物研发。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188921822","title":"異動解讀｜天辰生物-B盤中上漲51.05%，首掛上市獲超4762倍超額認購","url":"https://stock-news.laohu8.com/highlight/detail?id=1188921822","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188921822?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 09:30","pubTimestamp":1780623042,"startTime":"0","endTime":"0","summary":"6月5日，天辰生物-B首日挂牌上市，盘中上涨51.05%，报145.0港元，成交额3.02亿港元，较招股价96.06港元大幅溢价。消息面上，天辰生物-B本次IPO公开发售部分获4762.58倍超额认购，共接获约26.64万份有效申请，一手中签率仅约2%。此前暗盘交易报225.8港元，较招股价上涨逾135%，市场认购热情极高。天辰生物是一家临床阶段生物制药公司，专注于过敏性及自身免疫性疾病的生物药物自主发现与开发，核心产品LP-003为抗IgE抗体，已在中国启动八项临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641964196","title":"新股首日 | 天辰生物-B(01779)首掛上市 早盤高開50.22% 核心產品LP-003已在中國啓動八項臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2641964196","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641964196?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 09:21","pubTimestamp":1780622509,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，天辰生物-B首挂上市，公告显示，每股定价96.06港元，共发行1419.32万股股份，每手50股，所得款项净额约12.55亿港元。截至发稿，涨50.22%，报144.3港元，成交额2.99亿港元。公开资料显示，天辰生物是一家临床阶段生物制药公司，主要专注于针对过敏性及自身免疫性疾病的生物药物的自主发现与开发。公司的核心产品LP-003是一种抗IgE抗体，已在中国启动八项临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641196227","title":"《股市簡訊》中國天辰生物香港首秀盤初急漲64%，大金重工與龍豐集團雙雙「潛水」","url":"https://stock-news.laohu8.com/highlight/detail?id=2641196227","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641196227?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 09:21","pubTimestamp":1780622476,"startTime":"0","endTime":"0","summary":"《股市简讯》中国天辰生物香港首秀盘初急涨64%，大金重工与龙丰集团双双“潜水”* 香港三支新股周五首日挂牌表现不一，其中专注于过敏及免疫疾病的中国生物医药公司天辰生物1779.HK高开50%后，盘初扩大涨幅至64%至158港元，招股价则为96.06港元。* 香港连锁美妆及药品零售商--龙丰集团2290.HK低开17%后，盘初扩大跌幅至20%至4.12港元，招股价则为5.18港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nL4S42D02O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","01081","02290","BK0256","BK0120","002487"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107086499","title":"港股開盤 | 恒指低開0.27%，科指低開0.31%！天辰生物-B首掛升逾50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107086499","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107086499?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 09:20","pubTimestamp":1780622430,"startTime":"0","endTime":"0","summary":"6月5日，恒生指数开盘下跌67.28点，跌幅0.27%，报25186.12点；恒生科技指数开盘下跌15.43点，跌幅0.31%，报4959.93点；国企指数开盘下跌8.36点，跌幅0.1%，报8493.55点；红筹指数开盘下跌25.99点，跌幅0.59%，报4394.52点。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07500","82800","03067","03037","07226","03088","BK4588","03417","02833","HSI","VXUS","03032","09115","02800","01779","83115","07300","03423","03419","BK4585","02837","07200","HSTECH","09067","09088","03115","513600","07552","03033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127260818","title":"新股定價 | 天辰生物-B每股定價96.06港元，公開發售超購4762.58倍，一手中籤率2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127260818","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127260818?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 07:57","pubTimestamp":1780617420,"startTime":"0","endTime":"0","summary":"天辰生物-B（01779）公布配发结果。公司全球发售股份共计1419.315万股，最终发售价为每股96.06港元，募资净额约12.55亿港元，每手买卖单位为50股。H股预计于2026年6月5日（星期五）上午九时正起在联交所开始买卖。其中，香港公开发售部分获得4762.58倍超额认购，最终发售股份数目为141.94万股，占发售股份总数的10%。该部分共接获约26.64万份有效申请，受理申请数目约28057份，申购一手股份的获配发比例约为所申请股份总数的2%。国际配售部分获得10.94倍超额认购，最终发售股份数目为1277.38万股，占发售股份总数的90%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/dd692af5834cccf0a1114930c5817827","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/dd692af5834cccf0a1114930c5817827"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640082163","title":"天辰生物-B(01779)：香港公開發售獲4762.58倍認購 全球發售淨籌約12.55億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640082163","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640082163?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 22:29","pubTimestamp":1780583353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天辰生物-B(01779)公布配发结果，公司全球发售1419.315万股股份，香港公开发售占10%，国际发售占90%。最终发售价为每股96.06港元，全球发售净筹约12.55亿港元。每手50股，预期H股将于2026年6月5日(星期五)上午九时正(香港时间)开始在联交所买卖。其中，香港公开发售获4,762.58倍认购，国际发售获10.94倍认购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179817568","title":"天辰生物-B獲4,763倍超購、募資逾13億元　6月5日登陸港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1179817568","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179817568?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 22:26","pubTimestamp":1780583185,"startTime":"0","endTime":"0","summary":"天辰生物医药（苏州）股份有限公司完成香港联交所主板上市前全球发售，招股价定为每股96.06港元。本次全球发售共发行14,193,150股H股，募资总额约13.63亿元港元，扣除预计开支后净筹约12.55亿元港元。公司股票预计于2026年6月5日挂牌买卖，股份代号01779，每手50股。公开发售部分获266,377份有效申请，认购倍数高达4,762.58倍；获接纳申请28,057份，最终分配1,419,350股H股，占全球发售10%。国际发售配售12,773,800股H股，获80名承配人认购，超额认购10.94倍，占本次发行90%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640584031","title":"新股暗盤 | 天辰生物-B(01779)暗盤盤初漲逾135% 每手賺6487港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640584031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640584031?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 16:17","pubTimestamp":1780561037,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，天辰生物-B(01779)将于6月5日(周五)在香港挂牌。截至发稿，暗盘交易显示报价225.800港元，较招股价96.06港元上涨135.06%，每手50股，不计手续费，每手赚6487港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37d0231be6e823568bbf3b5d9ec33c9f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01779","EWH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}